New shot could make cancer treatment easier for patients with advanced tumors

NCT ID NCT07161414

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study tests a new way to give the drug rilvegostomig as a shot under the skin instead of through an IV. It is for adults with advanced solid tumors who have already tried standard treatments. The goal is to find a dose that works as well as the IV version and to check for side effects. About 40 people will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autosomal dominant Parkinson disease 4 neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMORS

Contacts and locations

Locations

Research Site
RECRUITING

Huntersville, North Carolina, 28078, United States
Research Site
RECRUITING

San Antonio, Texas, 78229, United States
Research Site
RECRUITING

Fairfax, Virginia, 22031, United States
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
NOT_YET_RECRUITING

Barcelona, 08035, Spain
Research Site
RECRUITING

Barcelona, 08036, Spain
Research Site
RECRUITING

Madrid, 28027, Spain
Research Site
RECRUITING

Madrid, 28040, Spain
Research Site
SUSPENDED

Newcastle upon Tyne, NE7 7DN, United Kingdom
Research Site
SUSPENDED

Sutton, SM2 5PT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.